Authors



Gennero Pagano, MD, MSc, PhD

Latest:

Positive Signs From Prasinezumab in Parkinson Disease: Gennero Pagano, MD, MSc, PhD

The expert medical director at Roche provided detail on results from the phase 2 PASADENA study presented at the 2021 MDS Virtual Congress. [WATCH TIME: 3 minutes]


Nina Browner, MD

Latest:

AUPN Leadership Minute Episode 14: Challenges of Virtual Residency Interviews

Episode 14 of the AUPN Leadership Minute features Alissa Willis, MD, of University of Mississippi Medical Center; and Nina Browner, MD, of University of North Carolina School of Medicine. [WATCH TIME: 5 minutes]


Mitchell Freedman, MD

Latest:

The Ever-Expanding Multiple Sclerosis Therapeutics

Join Ahmed Obeidat, MD, PhD; Mitchell Freedman, MD; and Suma Shah, MD, for the second program of this monthly series as they discuss the evolution of therapeutics for the treatment of multiple sclerosis.


Tracey A. Milligan, MD

Latest:

AUPN Leadership Minute Episode 35: Building a High-Quality QI Program

Episode 35 of the AUPN Leadership Minute features Tracey A. Milligan, MD, of New York Medical College; and Carl Gold, MD, MS, of Stanford University. [WATCH TIME: 5 minutes]


Mark S. Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC

Latest:

Emerging Therapies and Unmet Needs in MS

Drs Ahmed Zayed and Mark S. Freedman review emerging therapies in the pipeline and unmet needs in the multiple sclerosis treatment landscape, as well as take-home thoughts.


Alcibiades Rodiguez, MD

Latest:

Understanding Distinct Differences in Sleep Disorders to Ensure Accurate Diagnosis: Alcibiades J. Rodriguez, MD

The director of the Comprehensive Epilepsy Center—Sleep Center at NYU Langone provided perspective on the overlap in characteristics of sleep disorders and the necessary approach to ensuring accurate diagnosis and initial treatment. [WATCH TIME: 5 minutes]


Jeffrey M. Statland, MD

Latest:

Positive Impact of Ataluren on Walking Ability in Duchenne Muscular Dystrophy: Jeffrey M. Statland, MD

At the 2023 AAN Annual Meeting, the neuromuscular disease specialist and professor of neurology at the University of Kansas Medical Center talked about the phase 3 study investigating ataluren for Duchenne muscular dystrophy. [WATCH TIME: 5 minutes]


David Bates, PhD

Latest:

Integrating Machine Learning, Digital Platforms to Alzheimer Trials: David Bates, PhD

The chief executive officer and co-founder of Linus Health discussed screening tools for early cognitive decline and overcoming the complexities with using new-age technology. [WATCH TIME: 3 minutes]


Fred D. Lublin, MD

Latest:

Future of Relapsing MS Management

Key opinion leaders in multiple sclerosis (MS) discuss the future of relapsing MS management and unmet needs.


Solomon Moshe, MD

Latest:

Future Aspirations of Neonatal Seizure Research: Solomon Moshe, MD; Elissa Yozawitz, MD

The duo from Montefiore Medical Center discussed aspects of their recently published recommendations on neonatal seizure diagnosis that need further examining.


Bhupendra O. Khatri, MD, FAAN

Latest:

Navigating an Expanding Treatment Toolbox for MS

“Is more always better?”: The age-old question is more relevant than ever as clinicians and patients alike navigate an increasingly crowded MS treatment landscape.



Marshall C. Freeman, MD, FAHS, FAAN, FAANEM

Latest:

Optimizing the Migraine Consultation

Proper diagnosis and effective treatment planning can drastically improve quality of life for individuals with migraine.


Marc E. Agronin, MD

Latest:

Future of Treating Alzheimer Disease

Drs Richard S. Isaacson and Marc E. Agronin look to the future of treating Alzheimer disease with the emphasis on early diagnosis.


Hamid Khoja, PhD

Latest:

Assessing Efficacy of Fibroblast Cell Technology in MS and Directing Future Clinical Study: Hamid Khoja, PhD

Discussing data from an early safety study, the chief scientific officer of FibroBiologics commented on the benefits of a staggered approach to their clinical research in multiple sclerosis. [WATCH TIME: 5 minutes]


Muhammad "Mud" M Alvi, MD

Latest:

AUPN Leadership Minute Episode 38: Visa Issues for Faculty

Episode 38 of the AUPN Leadership Minute features Muhammad "Mud" Alvi, MD, of West Virginia University Robert C. Byrd Health; and David B. Watson, MD, of West Virginia University Robert C. Byrd Health. [WATCH TIME: 5 minutes]


Craig Blackstone, MD

Latest:

Guiding Medical Students Through Early Career Decisions: Craig Blackstone, MD

The chief of the Movement Disorders Division at Mass General Hospital discussed the challenges medical students face in pathing their career and the importance of a strong mentor figure. [WATCH TIME: 6 minutes]


Rita Perlingeiro, PhD

Latest:

Clinical Application of Induced Pluripotent Stem Cells in Muscular Dystrophy: Rita Perlingeiro, PhD

The Lillehei professor in stem cell and regenerative cardiovascular medicine at the University of Minnesota talked about the potential of investigating inducted pluripotent stem cells in neuromuscular diseases at MDA’s 2023 conference. [WATCH TIME: 5 minutes]


Dejan Jakimovski, MD, PhD

Latest:

Next Steps in Understanding Cognitive Decline in Aging MS: Dejan Jakimovski, MD, PhD

The research assistant professor at the Buffalo Neuroimaging Analysis Center provided context on how different forms of multiple sclerosis impact cognitive decline in patients. [WATCH TIME: 4 minutes]


Christina Szperka, MD, MSCE

Latest:

Using an Integrated EHR Questionnaire to Improve Diagnosis and Treatment in Pediatric Headache: Christina Szperka, MD, MSCE

The director of the Pediatric Headache Program at the Children’s Hospital of Philadelphia talked about the usage of an integrated EHR questionnaire to improve the likelihood of specific diagnosis in pediatric headache. [WATCH TIME: 5 minutes]


Jurriaan Peters, MD, PhD

Latest:

It Is Time to Redefine Outcomes in Pediatric Epilepsy Surgery

Successful epilepsy surgery in adults has been followed by forced normalization, depression, and memory issues, resulting in questions about the use of the metrics in the study of broader outcomes—a problem even more prominent in pediatric epilepsy surgery.


Anindita Deb, MD

Latest:

Advocacy and Empowerment: Finding Your Advocacy Community

The Palatucci Advocacy Leadership Forum, or PALF, sponsored by the American Academy of Neurology, gives neurologists and trainees tools to successfully advocate for their ideas and develop their identity as physician advocates.


Sharon Cohen, MD, FRCPC

Latest:

Importance of Early Diagnosis of Alzheimer’s Disease

Key opinion leaders emphasize the significance of early diagnosis in Alzheimer's disease, as it allows patients to make autonomous decisions and access early treatment options, including potential participation in clinical trials.


Nicholas Beimer, MD

Latest:

Early Awareness Towards Epilepsy Transition

Sucheta M. Joshi, MD, MS, FAES, FAAP, and Nicholas Beimer, MD, discussed the reasons why EpiTRAQ may influence earlier discussions with patients prior to the epilepsy transition process.


Mirla Avila, MD

Latest:

Addressing Diversity Gaps in Neuromyelitis Optica Spectrum Disorder Research: Mirla Avila, MD

The director of the Comprehensive Care MS Center at Texas Tech University Health Sciences Center talked about findings from a subgroup analysis of Hispanic or Latin patients from the N-MOmentum trial presented at ACTRIMS Forum 2024. [WATCH TIME: 3 minutes]


R. Scott Turner, MD, PhD, FANA, FAAN

Latest:

Achieving Greater Diversity in Dementia Research: A Call to Action

Achieving greater diversity in study populations is a focus of increasing scrutiny, priority, and funding in all medical research, including studies enrolling individuals on the continuum of prodromal Alzheimer disease, mild cognitive impairment, and Alzheimer disease.


Ponni Subbiah, MD, MPH

Latest:

Rett Syndrome Symptoms and Quality of Life Improvements Through Trofinetide: Ponni Subbiah, MD, MPH

The chief medical officer of Acadia Pharmaceuticals provided commentary on a caregiver analysis assessing beneficial experiences with trofinetide in patients with Rett syndrome. [WATCH TIME: 4 minutes]


Larissa Jank, MD

Latest:

Impact of Indole 3-Lactate Supplementation in Multiple Sclerosis Animal Models: Larissa Jank, MD

The postdoctoral researcher in the department of neurology at Johns Hopkins School of Medicine discussed findings from a study on the impact of indole 3-lactate supplementation in animal models of multiple sclerosis. [WATCH TIME: 4 minutes]


Erinn E. Beagin, MD

Latest:

Managing Insomnia: Practical Advice for Community Physicians

Closing their discussion on insomnia, panelists share final thoughts and advice for community physicians.

© 2024 MJH Life Sciences

All rights reserved.